Nystatin Topical News

Pacgen Reports Third Quarter Financial Results - Market Wire (press release)

Nystatin is a widely used, topical mouth rinse treatment for oral Candidiasis. This Phase IIb study, expected to be completed in Q2 2008, ...

http://www.marketwire.com/mw/rele... | Posted: Fri Feb 29 16:31:13 -0500 2008

Pacgen Reports Second Quarter Financial Results - Earthtimes

Nystatin is a widely used, topical mouth rinse treatment for oral Candidiasis. This Phase IIb study, expected to be completed in Q2 2008, ...

http://www.earthtimes.org/article... | Posted: Wed Nov 28 16:31:33 -0500 2007

Nov 13, 2007 VANCOUVER, BRITISH COLUMBIA MARKET WIRE - Genetic Engineering News (press release)

This study is a randomized, examiner-blinded, parallel design trial comparing three doses of PAC-113 to Nystatin mouthrinse. The study will enroll about 200 ...

http://www.genengnews.com/news/bn... | Posted: Tue Nov 13 08:47:16 -0500 2007

Pacgen announces positive results from Phase I/II trial of novel ... - PR-Inside.com (Pressemitteilung)

This Phase I/II study was a comparison between PAC-113 mouthrinse and Nystatin oral suspension. The study was a randomized, examiner-blinded, ...

http://www.pr-inside.com/pacgen-a... | Posted: Mon May 07 06:11:20 -0400 2007

Pacgen Announces Positive Results from Phase I/II Trial of Novel ... - PipelineReview.com (press release)

This Phase I/II study was a comparison between PAC-113 mouthrinse and Nystatin oral suspension. The study was a randomized, examiner-blinded, ...

Posted: Tue May 08 20:52:06 -0400 2007

Nystatin Topical

Post a new Nystatin Topical Side Effect

Ask a Question about Nystatin Topical

All Nystatin Topical Questions

Nystatin Topical in the News

Add Nystatin Topical to my cabinet

Nystatin Topical Home Page

All Nystatin Topical Side Effects

Nystatin Topical RSS Feed